Newsfeed

This area is a possible form of presentation for the integration of news sources relating to listed companies.
The presentation level is a template based on short news services, where users can get a quick overview of the latest news. The detailed views enable further research if interested.

This newsfeed is a compilation of current news from direct connections of TopTier NewsWire services related to listed companies. This feed is for demonstration purposes only. Sector-specific news, public relations and product information can be accessed via the GICS portals > Sector Intelligence section.

US4330001060
Reset filter
Do you already know our new terminal view? Click here.
FIGI: BBG00Q53VYM7
HIMS
Hims & Hers Health Inc
GICS: Health Care · SECTOR: EQTY · SUB-SECTOR: Household & Personal Products · THEMEFOLIO: $HLTH
NAME
Hims & Hers Health Inc
ISIN
US4330001060
TICKER
HIMS
MIC
XNYS
REUTERS
HIMS.N
BLOOMBERG
HIMS US
Mon, 24.08.2026       Hims & Hers Health
US4330001060

Scott+Scott Attorneys at Law LLP has launched an urgent investigation into whether certain officers and directors of Hims & Hers Health, Inc. (NYSE: HIMS) failed to manage Hims & Hers in an acceptable manner, breaching their fiduciary duties to Hims & Hers, and whether Hims & Hers and its shareholders have suffered damages as a res...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Fri, 21.08.2026       Hims & Hers Health
US4330001060

New York, New York--(Newsfile Corp. - August 21, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Hims & Hers Health, Inc. ("Hims & Hers" or the "Company") (NYSE: HIMS).CLICK HERE TO RECEIVE MORE INFORMATION ABOUT THIS INVESTIGATIONIf you are a Hims & Hers investor and have suffered losses...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Wed, 19.08.2026       Hims & Hers Health
US4330001060

SAN FRANCISCO, Aug. 19, 2026 /PRNewswire/ -- investors in Hims & Hers Health, Inc. (NYSE: HIMS) saw the price of their shares slide about 14% lower on news that the FTC sued the company over alleged improper business practices. The events have prompted national shareholders right...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Wed, 19.08.2026       Hims & Hers Health
US4330001060

New York, New York--(Newsfile Corp. - August 19, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Hims & Hers Health, Inc. ("Hims & Hers" or the "Company") (NYSE: HIMS).CLICK HERE TO RECEIVE MORE INFORMATION ABOUT THIS INVESTIGATIONIf you are a Hims & Hers investor and have suffered losses...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Wed, 19.08.2026       Hims & Hers Health
US4330001060

Philadelphia, Pennsylvania--(Newsfile Corp. - August 19, 2026) - National plaintiffs' law firm Berger Montague PC announces an investigation into the Board of Directors of Hims & Hers Health, Inc. (NYSE: HIMS) ("Hims & Hers" or the "Company") for potential breaches of fiduciary duties owed to the Company and its shareholders. The investigat...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Wed, 19.08.2026       Hims & Hers Health
US4330001060

RADNOR, Pa., Aug. 18, 2026 /PRNewswire/ -- Kessler Topaz Meltzer & Check, LLP (www.ktmc.com), a nationally recognized securities litigation law firm, is investigating potential violations of the federal securities laws by Hims & Hers Health, Inc. (NYSE: HIMS) on behalf of investors who purchased or acquired Hims & Hers Health, Inc. sec...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Mon, 17.08.2026       Hims & Hers Health
US4330001060

New York, New York--(Newsfile Corp. - August 17, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Hims & Hers Health, Inc. ("Hims & Hers" or the "Company") (NYSE: HIMS).CLICK HERE TO RECEIVE MORE INFORMATION ABOUT THIS INVESTIGATIONIf you are a Hims & Hers investor and have suffered losses...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Fri, 14.08.2026       Hims & Hers Health
US4330001060

New York, New York--(Newsfile Corp. - August 14, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Hims & Hers Health, Inc. ("Hims & Hers" or the "Company") (NYSE: HIMS).CLICK HERE TO RECEIVE MORE INFORMATION ABOUT THIS INVESTIGATIONIf you are a Hims & Hers investor and have suffered losses...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Thu, 13.08.2026       Hims & Hers Health
US4330001060

The law firm of Kirby McInerney LLP reminds investors of its investigation on behalf of Hims & Hers Health, Inc. (“Hims” or the “Company”) (NYSE: HIMS) investors concerning the Company’s and/or members of its senior management’s possible violation of the federal securities laws or other unlawful business practices.[LEARN MORE ABOUT THE INVESTIG...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Wed, 12.08.2026       Hims & Hers Health
US4330001060

RADNOR, Pa., Aug. 12, 2026 /PRNewswire/ -- Kessler Topaz Meltzer & Check, LLP (www.ktmc.com), a nationally recognized securities litigation law firm, is investigating potential violations of the federal securities laws by Hims & Hers Health, Inc. (NYSE: HIMS) on behalf of investors who purchased or acquired Hims & Hers Health, Inc. sec...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Silent Ad
Wed, 12.08.2026       Hims & Hers Health
US4330001060

New York, New York--(Newsfile Corp. - August 12, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Hims & Hers Health, Inc. ("Hims & Hers" or the "Company") (NYSE: HIMS).CLICK HERE TO RECEIVE MORE INFORMATION ABOUT THIS INVESTIGATIONIf you are a Hims & Hers investor and have suffered losses...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Wed, 12.08.2026       Hims & Hers Health
US4330001060

PHILADELPHIA, Aug. 12, 2026 /PRNewswire/ -- National plaintiffs' law firm Berger Montague PC announces an investigation into the Board of Directors of Hims & Hers Health, Inc. (NYSE: HIMS) ("Hims & Hers" or the "Company") for potential breaches of fiduciary duties owed to the Company and its shareholders. The investigation is focused on wh...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Tue, 11.08.2026       Hims & Hers Health
US4330001060

New York, New York--(Newsfile Corp. - August 11, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Hims & Hers Health, Inc. ("Hims & Hers" or the "Company") (NYSE: HIMS).CLICK HERE TO RECEIVE MORE INFORMATION ABOUT THIS INVESTIGATIONIf you are a Hims & Hers investor and have suffered losses...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Mon, 10.08.2026       Hims & Hers Health
US4330001060

Hims & Hers Health, Inc. (“Hims & Hers” or the “Company”, NYSE: HIMS), the leading global health and wellness platform, today announced financial results for the second quarter ended June 30, 2026. “Hims & Hers is delivering a world-class health experience at a global scale and a reasonable price for the nearly 3 million people who r...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Mon, 10.08.2026       Hims & Hers Health
US4330001060

Scott+Scott Attorneys at Law LLP has launched an urgent investigation into whether certain officers and directors of Hims & Hers Health, Inc. (NYSE: HIMS) failed to manage Hims & Hers in an acceptable manner, breaching their fiduciary duties to Hims & Hers, and whether Hims & Hers and its shareholders have suffered damages as a res...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Mon, 10.08.2026       Hims & Hers Health
US4330001060

New York, New York--(Newsfile Corp. - August 10, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Hims & Hers Health, Inc. ("Hims & Hers" or the "Company") (NYSE: HIMS).CLICK HERE TO RECEIVE MORE INFORMATION ABOUT THIS INVESTIGATIONIf you are a Hims & Hers investor and have suffered losses...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Fri, 07.08.2026       Hims & Hers Health
US4330001060

New York, New York--(Newsfile Corp. - August 7, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Hims & Hers Health, Inc. ("Hims & Hers" or the "Company") (NYSE: HIMS).CLICK HERE TO RECEIVE MORE INFORMATION ABOUT THIS INVESTIGATIONIf you are a Hims & Hers investor and have suffered losses,...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Thu, 06.08.2026       Hims & Hers Health
US4330001060

Hims & Hers, the leading health and wellness platform, today announced a first-of-its-kind* intelligent care experience that puts AI directly inside customers’ care, not on the sidelines of it. Rolling out first to Hers weight loss members, this proactive care experience delivers personalized guidance, real-time attention to her progress, and...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Wed, 05.08.2026       Hims & Hers Health
US4330001060

RADNOR, Pa., Aug. 5, 2026 /PRNewswire/ -- Kessler Topaz Meltzer & Check, LLP (www.ktmc.com), a nationally recognized securities litigation law firm, is investigating potential violations of the federal securities laws by Hims & Hers Health, Inc. (NYSE: HIMS) on behalf of investors who purchased or acquired Hims & Hers Health, Inc. secu...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Wed, 05.08.2026       Hims & Hers Health
US4330001060

Philadelphia, Pennsylvania--(Newsfile Corp. - August 5, 2026) - National plaintiffs' law firm Berger Montague PC announces an investigation into the Board of Directors of Hims & Hers Health, Inc. (NYSE: HIMS) ("Hims & Hers" or the "Company") for potential breaches of fiduciary duties owed to the Company and its shareholders. The investigati...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Silent Ad
Tue, 04.08.2026       Hims & Hers Health
US4330001060

New York, New York--(Newsfile Corp. - August 3, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Hims & Hers Health, Inc. ("Hims & Hers" or the "Company") (NYSE: HIMS).CLICK HERE TO RECEIVE MORE INFORMATION ABOUT THIS INVESTIGATIONIf you are a Hims & Hers investor and have suffered losses,...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Mon, 03.08.2026       Hims & Hers Health
US4330001060

Kessler Topaz Meltzer & Check, LLP (www.ktmc.com), a nationally recognized securities litigation law firm, is investigating potential violations of the federal securities laws by Hims & Hers Health, Inc. (NYSE: HIMS) on behalf of investors who purchased or acquired Hims & Hers Health, Inc. securities and experienced significant financi...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Fri, 31.07.2026       Hims & Hers Health
US4330001060

LOS ANGELES, July 31, 2026 /PRNewswire/ -- Schall, Brown & Schwartz LLP ("SBS"), a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Hims & Hers Health, Inc. (" Hims & Hers" or "the Company") (NYSE: HIMS) for violations of the securities laws. INVESTIGATION DETAILS: The inv...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Thu, 30.07.2026       Hims & Hers Health
US4330001060

New York, New York--(Newsfile Corp. - July 30, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Hims & Hers Health, Inc. ("Hims & Hers" or the "Company") (NYSE: HIMS).CLICK HERE TO RECEIVE MORE INFORMATION ABOUT THIS INVESTIGATIONIf you are a Hims & Hers investor and have suffered losses,...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Thu, 30.07.2026       Hims & Hers Health
US4330001060

Schall, Brown & Schwartz LLP (“SBS”), a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Hims & Hers Health, Inc. (“ Hims & Hers” or “the Company”) (NYSE: HIMS) for violations of the securities laws. INVESTIGATION DETAILS: The investigation focuses on whether the Company...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Thu, 30.07.2026       Hims & Hers Health
US4330001060

Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Hims & Hers Health, Inc. (“Hims” or the “Company”) (NYSE: HIMS) investors concerning the Company’s possible violations of the federal securities laws.IF YOU ARE AN INVESTOR WHO LOST MONEY ON...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Thu, 30.07.2026       Hims & Hers Health
US4330001060

Law Offices of Howard G. Smith announces an investigation on behalf of Hims & Hers Health, Inc. (“Hims” or the “Company”) (NYSE: HIMS) investors concerning the Company’s possible violations of federal securities laws.IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN HIMS & HERS HEALTH, INC. (HIMS), CONTACT THE LAW OFFICES OF HOWARD G. SMITH ABO...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Wed, 29.07.2026       Hims & Hers Health
US4330001060

The Law Offices of Frank R. Cruz announces an investigation of Hims & Hers Health, Inc. (“Hims” or the “Company”) (NYSE: HIMS) on behalf of investors concerning the Company’s possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON HIMS & HERS HEALTH, INC. (HIMS), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PU...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Wed, 29.07.2026       Hims & Hers Health
US4330001060

Hims & Hers Health, Inc. (NYSE: HIMS) responded to the lawsuit filed today by the Federal Trade Commission (FTC): This lawsuit disregards substantial evidence we provided the FTC during its nearly three-year investigation, ignores established state laws and industry standards in telehealth, and contorts the law to try to manufacture claims....
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Fri, 17.07.2026       Hims & Hers Health
US4330001060

Hims & Hers Health, Inc. (NYSE: HIMS), the leading health and wellness platform, today announced its Chief Accounting Officer, Irene Becklund will depart the company after more than seven years, effective October 9, 2026. Becklund will then serve as an advisor to the company for several months to assist with the transition. The company will co...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Mon, 13.07.2026       Hims & Hers Health
US4330001060

Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading health and wellness platform, today announced that it will report second quarter 2026 financial results after the market closes on Monday, August 10, 2026. The company will host a live conference call to discuss the results at 5:00 p.m. ET the same day. The conference call...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Thu, 04.06.2026       Hims & Hers Health
US4330001060

Hims & Hers Health, Inc. (NYSE: HIMS), the leading health and wellness platform, today announced Dr. Anant Vinjamoori is joining as the Chief Medical Officer of the Hims brand. As the company reimagines how everyone can access proactive, comprehensive care that helps them feel great, Dr. Vinjamoori will provide the clinical guidance that shape...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Tue, 02.06.2026       Hims & Hers Health
US4330001060

Hims & Hers Health, Inc. has completed its acquisition of Eucalyptus, the parent company of Juniper, advancing its position as the world's largest consumer health platform. In Germany, the closing strengthens Juniper’s comprehensive, clinically rigorous, weight management offering with the technology, data, and infrastructure of Hims & Her...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Tue, 02.06.2026       Hims & Hers Health
US4330001060

Hims & Hers Health, Inc. today announced the completion of its acquisition of Eucalyptus, the parent company of Juniper, marking the latest in a series of significant company investments in Canada. Since launching in 2025, Hims & Hers has already changed the game in Canada, becoming the first platform to bring generic semaglutide to eligib...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Tue, 02.06.2026       Hims & Hers Health
US4330001060

Hims & Hers Health, Inc. has completed its acquisition of Eucalyptus, the parent company of Juniper, marking a significant milestone in the company's global growth and its formal entry into Japan. This milestone puts the full weight of Hims & Hers’ technology, data, and clinical infrastructure behind a platform that supports weight managem...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Tue, 02.06.2026       Hims & Hers Health
US4330001060

Hims & Hers Health, Inc. has completed its acquisition of Eucalyptus – the parent company of Juniper, Pilot, Kin, and Software – advancing its position as the world's largest consumer health platform and marking its official entry into Australia. This milestone puts the full weight of Hims & Hers’ technology, data, and clinical infrastruct...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Tue, 02.06.2026       Hims & Hers Health
US4330001060

Hims & Hers Health, Inc. (NYSE: HIMS) has completed its acquisition of Eucalyptus, advancing its position as the world's largest consumer health platform. Building on the earlier acquisitions of ZAVA and Livewell, Hims & Hers now has a leading presence across the US, UK, Australian, and Canadian markets, with a growing presence in France,...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Thu, 28.05.2026       Hims & Hers Health
US4330001060

Hims & Hers Health, Inc. (NYSE: HIMS), the leading health and wellness platform, today announced the expansion of Hims & Hers Benefits, adding eight new partners to the Hims & Hers exclusive program. Joining founding partners Prenuvo and Eight Sleep are Natural Cycles, MyFitnessPal, Ladder, PVOLVE Studios, HelloFresh, Factor, Flo Healt...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Thu, 21.05.2026       Hims & Hers Health
US4330001060

Hims & Hers Health, Inc. (NYSE: HIMS), the leading health and wellness platform, today announced the availability of generic semaglutide through its platform for eligible customers in Canada. This makes affordable GLP-1 treatment accessible to Canadians for whom cost has long been a barrier to treatment. For eligible customers, personalised tr...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Thu, 21.05.2026       Hims & Hers Health
US4330001060

Hims & Hers Health, Inc. (NYSE: HIMS), the leading health and wellness platform, today announced the availability of generic semaglutide through its platform in Canada. This is Hims & Hers’ first international generic GLP-1 offering, demonstrating the company’s ability to meet the unique needs of each global market it serves while continui...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Tue, 19.05.2026       Hims & Hers Health
US4330001060

Hims & Hers Health, Inc. (“Hims & Hers” or the “Company”, NYSE: HIMS) today announced the pricing of its offering of $350 million aggregate principal amount of 0.00% convertible senior notes due 2032 (the “notes”) in a private offering to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Secur...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Mon, 18.05.2026       Hims & Hers Health
US4330001060

Hims & Hers Health, Inc. (“Hims & Hers” or the “Company”, NYSE: HIMS) today announced its intention to offer, subject to market and other conditions, $300 million aggregate principal amount of convertible senior notes due 2032 (the “notes”) in a private offering to persons reasonably believed to be qualified institutional buyers pursuant t...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Mon, 11.05.2026       Hims & Hers Health
US4330001060

Hims & Hers Health, Inc. (“Hims & Hers” or the “Company”, NYSE: HIMS), the leading health and wellness platform, today announced financial results for the first quarter ended March 31, 2026. Moving forward, the Company plans to transition to an annual rather than quarterly shareholder letter and will continue to provide regular updates thr...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Tue, 28.04.2026       Hims & Hers Health
US4330001060

Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading health and wellness platform, has nominated Kofi Amoo-Gottfried for election as a new director at the company’s 2026 annual shareholder meeting in June. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260428343333...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Mon, 13.04.2026       Hims & Hers Health
US4330001060

Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading health and wellness platform, today announced that it will report first quarter 2026 financial results after the market closes on Monday, May 11, 2026. The company will host a live conference call to discuss the results at 5:00 p.m. ET the same day. The conference call can...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Fri, 03.04.2026       Hims & Hers Health
US4330001060

Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into Hims & Hers Health, Inc. (“Hims” or the “Company”) (NYSE: HIMS). On June 23, 2025, Novo Nordisk announced that it was terminating its partnership with Hims &...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Thu, 26.03.2026       Hims & Hers Health
US4330001060

Hims & Hers Health, Inc. (NYSE: HIMS) today announced that a broad assortment of Novo Nordisk’s FDA-approved GLP-1 medications are available to eligible customers, including the Wegovy® pill, which is the only FDA-approved GLP-1 weight loss pill.1 As a part of a collaboration with Novo Nordisk, Hims & Hers is making it simpler for customer...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Sat, 21.03.2026       Hims & Hers Health
US4330001060

NEW YORK and NEW ORLEANS, March 20, 2026 /PRNewswire/ -- Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC ("KSF"), announces that KSF has commenced an investigation into Hims & Hers Health, Inc. ("Hims" or the "Company") (NYSE: HIMS)....
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Wed, 11.03.2026       Hims & Hers Health
US4330001060

Hims & Hers Health, Inc. (NYSE: HIMS), the leading global health and wellness platform, today announced the appointment of Kathryn Beiser as Chief Communications Officer. In this role, Beiser will lead external and internal communications for the company as it enters a new phase of domestic and international growth. In her role as CCO, Beiser...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Tue, 10.03.2026       Hims & Hers Health
US4330001060

Hims & Hers Health, Inc. (NYSE: HIMS), the leading health and wellness platform, today announced Hims & Hers Benefits, a new way for subscribers to access the best innovations in whole body health. This new initiative provides active subscribers access to discounts from health partners, all in one place, including whole body MRI scans from...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink